InMed Pharmaceuticals Inc (INM)vsTeva Pharma Industries Ltd ADR (TEVA)
INM
InMed Pharmaceuticals Inc
$1.36
+2.26%
HEALTHCARE · Cap: $7.58M
TEVA
Teva Pharma Industries Ltd ADR
$41.10
+0.09%
HEALTHCARE · Cap: $46.10B
Smart Verdict
WallStSmart Research — data-driven comparison
Teva Pharma Industries Ltd ADR generates 350222% more annual revenue ($17.32B vs $4.94M). TEVA leads profitability with a 4.1% profit margin vs 0.0%. TEVA earns a higher WallStSmart Score of 46/100 (D+).
INM
Avoid28
out of 100
Grade: F
TEVA
Hold46
out of 100
Grade: D+
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Safe zone — low bankruptcy risk
Earnings expanding 72.2% YoY
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Operating margin of 0.0%
4.1% margin — thin
Operating margin of 4.0%
Premium valuation, high expectations priced in
Revenue declined 0.8%
Comparative Analysis Report
WallStSmart ResearchBull Case : INM
The strongest argument for INM centers on Altman Z-Score.
Bull Case : TEVA
The strongest argument for TEVA centers on EPS Growth. PEG of 1.29 suggests the stock is reasonably priced for its growth.
Bear Case : INM
The primary concerns for INM are EPS Growth, Market Cap, Profit Margin.
Bear Case : TEVA
The primary concerns for TEVA are Profit Margin, Operating Margin, P/E Ratio. A P/E of 65.9x leaves little room for execution misses. Debt-to-equity of 2.18 is elevated, increasing financial risk.
Key Dynamics to Monitor
INM carries more volatility with a beta of 0.98 — expect wider price swings.
TEVA is growing revenue faster at -0.8% — sustainability is the question.
TEVA generates stronger free cash flow (307M), providing more financial flexibility.
Monitor DRUG MANUFACTURERS - SPECIALTY & GENERIC industry trends, competitive dynamics, and regulatory changes.
Bottom Line
TEVA scores higher overall (46/100 vs 28/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
InMed Pharmaceuticals Inc
HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC · USA
InMed Pharmaceuticals Inc., a clinical-stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company is headquartered in Vancouver, Canada.
Teva Pharma Industries Ltd ADR
HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC · USA
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic drugs, specialty drugs, and biopharmaceuticals in North America, Europe, and internationally. The company is headquartered in Petach Tikva, Israel.
Compare with Other DRUG MANUFACTURERS - SPECIALTY & GENERIC Stocks
Want to dig deeper into these stocks?